Innovation New Jersey
  • Home
  • Our Coalition
    • Contact Us
  • News
  • Resources
    • State Supports
    • Federal Supports
    • Higher Ed Supports
  • Join Us

Innovation News

Everything Innovation. Everything New Jersey.
Follow us and stay connected.

U.S. Biopharmaceutical Companies Launch GoBOLDLY, A Groundbreaking, Multi-Year Initiative Heralding New Era of Medicine

1/27/2017

0 Comments

 
Washington, DC — The Pharmaceutical Research and Manufacturers of America (PhRMA) on January 23 launched a national, multi-year advertising and public affairs initiative on behalf of America’s biopharmaceutical companies.
 
The campaign, GOBOLDLY, will showcase the industry’s unsung heroes driving cutting-edge advances in science and highlight the tremendous opportunity that exists to tackle our most complex and devastating health conditions.
 
“Thanks to the tireless work of biopharmaceutical researchers and scientists, we have entered a new era of medicine that is transforming the way we prevent and treat disease.  This campaign spotlights their perseverance and unwavering commitment to American patients for whom we all work,” said Stephen J. Ubl, president and chief executive officer of PhRMA.


“We will also be convening events with stakeholders all across the country to discuss ways we can work together to make our health care system more responsive to the needs of patients,” Ubl said.
​The campaign will include national TV, print, digital, radio and out-of-home advertising.
 
A new website, GoBoldly.com, will provide visitors with more information about the topics and themes featured in campaign advertisements, and a redesigned Innovation.org will provide in-depth information about exciting advances in biopharmaceutical innovation.
 
#GoBoldly will be used across social media platforms to salute the sheer will and tenacity of patients and scientists fighting against disease every day.
 
Revolutionary biopharmaceutical science is the central theme of the campaign advertisements featured at launch.
 
Do Not Go Gentle, the first TV advertisement, features the iconic poem by Dylan Thomas and highlights real biopharmaceutical scientists who have an indomitable will to find the unfindable and cure the incurable.  
 
Cells highlights exciting scientific advances that are happening at the cellular level and will be featured in print and digital advertisements.
 
Additional advertisements will be introduced throughout the year focusing on bold advancements in science and featuring the stories of real researchers who are driving these cutting-edge advances alongside patients benefiting from the medicines that are being developed.
 
In addition to paid advertising, the campaign will include comprehensive public affairs activities to foster a national dialogue with researchers, caregivers, patients and policymakers in forums around the country.
 
These discussions will focus on what the new era in medicine means for patients and the health care system and the types of public policy solutions that are needed to sustain this progress.
 
“Through partnerships and collaborations with other health care leaders,” Ubl said, “we will work to advance commonsense solutions that foster the continued development of new medicines, enhance the private marketplace and provide patients with access to the newest and most innovative treatments.”
 
The campaign will include three distinct public affairs initiatives around the following core areas: bold advancements in science, value-driven health care and public health.
 
These efforts will officially kick off in February and March.
 
  • The New Era of Medicine: An initiative convened by the scientists at America’s biopharmaceutical companies to foster a national dialogue on bold advancements in science.
 
  • The Value Collaborative: An effort to engage stakeholders across the health care system to advance policy solutions that will enable the private sector to lead the move to a value-driven health care system.
 
  • Public Health: A public outreach and education campaign around critical public health issues facing America today.
 
To learn more, visit GoBoldly.com and Innovation.org and to view the campaign’s new TV spot, click here
 
About PhRMA
 
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier and more productive lives.
 
Since 2000, PhRMA member companies have invested more than half a trillion dollars in the search for new treatments and cures, including an estimated $58.8 billion in 2015 alone.
 
 
0 Comments



Leave a Reply.

    Do not miss a single innovative moment and sign up for our newsletter!
    Weekly updates


    Categories

    All
    3D Printing
    Academia
    Acquisitions
    Aerospace
    Agriculture
    AIDS
    Algae
    Alumni
    Animals
    Architecture
    Astrophysics
    Autism
    Awards
    Big Data
    Bioethics
    Biofuel
    Biomedical
    BioNJ
    Bioterrorism
    Bit Coins
    Brain Health
    Business
    Camden
    Cancer
    CCollege
    Cellular
    Centenary
    Chemistry
    ChooseNJ
    Climate Change
    Clinical Trials
    Cloud Tech
    Collaboration
    Computing
    Congress
    Coriell
    Council On Innovation
    Crowdfunding
    Cybersecurity
    DARPA
    Defense
    Degree
    Dementia
    Dental Health
    DOC
    DOD
    DOE
    Drew
    Drones
    Drug Creation
    Einstein's Alley
    Electricity
    Energy
    Engineering
    Entrepreneurship
    Environmental
    FAA
    Fairleigh Dickinson
    FDA
    Federal Budget
    Federal Government
    Federal Labs
    Federal Program
    Finance
    Food Science
    Fort Monmouth
    Fuel Cells
    Funding
    Genome
    Geography
    Geology
    Global Competition
    Google
    Governor Christie
    Grant
    Hackensack
    HackensackUMC
    Healthcare
    Health Care
    HHS
    HINJ
    Hospitals
    Immigration
    Incubator
    Infrastructure
    International
    Internet
    Investor
    IoT
    IP
    IT
    Jobs
    Johnson & Johnson
    K-12
    Kean
    Kessler
    Legislation
    Logistics
    Manufacturing
    Medical Devices
    Med School
    Mental Health
    Mentor
    Microorganisms
    Molecular Biology
    Montclair
    NAS
    Neuroscience
    Newark
    New Jersey
    NIFA
    NIH
    NIST
    NJBDA
    NJBIA
    NJ Chemistry Council
    NJCU
    NJDOLWD
    NJEDA
    NJEDge
    NJHF
    NJII
    NJIT
    NJMEP
    NJPAC
    NJPRO
    NJTC
    Nonprofit
    NSF
    OpEd
    Open Data
    OSHE
    OSTP
    Parasite
    Patents
    Paterson
    Patients
    Perth Amboy
    Pharma
    POTUS
    PPPL
    Princeton
    Prosthetics
    Ranking
    Rare Disease
    R&D Council
    Report
    Resiliency
    Rider
    Robotics
    Rowan
    Rutgers
    SBA
    Seton Hall
    Siemens
    Smart Car
    Smart Cities
    Software
    Solar
    Space
    SSTI
    Startup
    State Government
    STEM
    Stevens
    Stockton
    Subatomic
    Supports
    Sustainability
    Taxes
    TCNJ
    Teachers
    Telecom
    Therapy
    Thermodynamics
    Transportation
    Undergraduate
    USEDA
    Verizon
    Video Game
    Virtual Reality
    Water
    WHO
    William Paterson
    Women In STEM
    Workforce Development

Home   Coalition   News   Resources   Events   Join Us
Picture
Innovation New Jersey Coalition
222 West State Street
Suite 302
Trenton, NJ 08608
732-729-9619